A short story about us

CRISPNet is a specialist IMP-management tool developed by AGC DATA for Clinical Trials of Investigational Medicinal Products.

It works alongside electronic data capture systems such as REDCap to support secure, traceable and efficient trial workflows—from randomisation and IMP allocation through to accountability, stock monitoring and emergency unblinding.

What CRISPNet can support

Depending on the requirements of your protocol, CRISPNet can provide:

• Randomisation and treatment allocation

• Maintenance of study blinding

• IMP pack allocation

• Pharmacy dispensing workflows

• Inventory and stock monitoring

• Batch and expiry-date tracking

• Drug accountability

• Returns and destruction records

• Automated notifications

• Emergency unblinding

• Role-based access

• Complete audit trails

Each implementation is configured around the study protocol, participating sites, pharmacy processes and sponsor requirements.

CRISPNet IMP Management for CTIMPs

Designed around your study

CRISPNet is not a fixed commercial platform that requires your protocol to fit a predetermined workflow.

The system is configured around the needs of the study, allowing AGC DATA to develop the level of infrastructure required without adding unnecessary features or complexity.

Relevant controls may include:

• Role-based permissions

• Multi-factor authentication

• Restricted access to unblinded information

• Automated data validation

• Traceable system activity

• Controlled system integrations

• Regional hosting

• Documented testing and change control

The specific compliance and validation approach is agreed for each project based on the study’s risks, responsibilities and regulatory context.